• 1
    Hayakawa, H., Hayakawa, M., Kume, A. and Tominaga, S., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 2007. 282: 2636926380.
  • 2
    Tominaga, S., A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 1989. 258: 301304.
  • 3
    Klemenz, R., Hoffmann, S. and Werenskiold, A. K., Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc. Natl. Acad. Sci. USA 1989. 86: 57085712.
  • 4
    Trub, T., Kalousek, M. B., Frohli, E. and Klemenz, R., Growth factor-mediated induction of the delayed early gene T1 depends on a 12-O-tetradecanoylphorbol 13-acetate-responsive element located 3.6 kb upstream of the transcription initiation site. Proc. Natl. Acad. Sci. USA 1994. 91: 38963900.
  • 5
    Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. and Tominaga, S., Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 1993. 318: 8387.
  • 6
    Gachter, T., Werenskiold, A. K. and Klemenz, R., Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J. Biol. Chem. 1996. 271: 124129.
  • 7
    Hayakawa, M., Yanagisawa, K., Aoki, S., Hayakawa, H., Takezako, N. and Tominaga, S., T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. Biochim. Biophys. Acta 2005. 1728: 5364.
  • 8
    Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P. and Busslinger, M., Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO. J. 1994. 13: 11761188.
  • 9
    Oshikawa, K., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K., Ohno, S., Tominaga, S. I. et al., Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 2001. 164: 277281.
  • 10
    Becerra, A., Warke, R. V., de Bosch, N., Rothman, A. L. and Bosch, I., Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 2008. 41: 114120.
  • 11
    Kuroiwa, K., Arai, T., Okazaki, H., Minota, S. and Tominaga, S., Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 2001. 284: 11041108.
  • 12
    Shah, R. V. and Januzzi, J. L., Jr., ST2: a novel remodeling biomarker in acute and chronic heart failure. Curr. Heart Fail Rep. 2010. 7: 914.
  • 13
    Kumar, S., Tzimas, M. N., Griswold, D. E. and Young, P. R., Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 1997. 235: 474478.
  • 14
    Lecart, S., Lecointe, N., Subramaniam, A., Alkan, S., Ni, D., Chen, R., Boulay, V., et al., Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur. J. Immunol. 2002. 32: 29792987.
  • 15
    Prechtel, D., Harbeck, N., Berger, U., Hofler, H. and Werenskiold, A. K., Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab. Invest. 2001. 81: 159165.
  • 16
    Haga, Y., Yanagisawa, K., Ohto-Ozaki, H., Tominaga, S., Masuzawa, T. and Iwahana, H., The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G. Eur. J. Biochem. 2003. 270: 163170.
  • 17
    Kurokawa, M., Matsukura, S., Kawaguchi, M., Ieki, K., Suzuki, S., Odaka, M., Watanabe, S., et al., Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int. Arch. Allergy Immunol. 2011. 155(Suppl 1): 1220.
  • 18
    Hueber, A. J., Alves-Filho, J. C., Asquith, D. L., Michels, C., Millar, N. L., Reilly, J. H., Graham, G. J. et al., IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur. J. Immunol. 2011. 41: 22292237.
  • 19
    Iwahana, H., Yanagisawa, K., Ito-Kosaka, A., Kuroiwa, K., Tago, K., Komatsu, N., Katashima, R., et al., Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem. 1999. 264: 397406.
  • 20
    Li, H., Tago, K., Io, K., Kuroiwa, K., Arai, T., Iwahana, H., Tominaga, S., et al., The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000. 67: 284290.
  • 21
    Marvie, P., Lisbonne, M., L'Helgoualc'h, A., Rauch, M., Turlin, B., Preisser, L., Bourd-Boittin, et al., Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J. Cell Mol. Med. 2009. 14: 17261739.